Variant forms of ER-β have been identified that are co-expressed with wild-type ER-β in MDA231 breast cancer cells (Fuqua et al, 1999; Leygue et al, 1999; Vladusic et al, 1998, 2000). This evidence concerns the gene ESR2 and breast carcinoma.